Heron Therapeutics, Inc. /De/

NEW YORK STATE COMMON RETIREMENT FUND HRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

2,576,716

Value ($000)

3,350

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	3,350	0.0%	2,576,716	12/31/2025
2025 Q3	11/3/2025	3,247	0.0%	2,576,716	9/30/2025
2025 Q2	10/8/2025	3,643	0.0%	1,760,045	6/30/2025
2025 Q1	10/8/2025	3,856	0.0%	1,752,924	3/31/2025
2024 Q4	10/8/2025	2,021	0.0%	1,321,006	12/31/2024
2024 Q3	10/8/2025	2,547	0.0%	1,279,944	9/30/2024
2024 Q2	10/8/2025	4,357	0.0%	1,244,923	6/30/2024
2024 Q1	10/8/2025	3,031	0.0%	1,094,116	3/31/2024
2023 Q4	10/8/2025	1,860	0.0%	1,094,164	12/31/2023
2023 Q3	10/8/2025	1,127	0.0%	1,094,441	9/30/2023
2023 Q2	10/8/2025	1,289	0.0%	1,110,876	6/30/2023
2023 Q1	10/8/2025	1,617	0.0%	1,071,124	3/31/2023
2022 Q4	10/8/2025	2,748	0.0%	1,099,050	12/31/2022
2022 Q3	11/8/2022	3,960	0.0%	938,352	9/30/2022
2022 Q2	8/4/2022	2,253	0.0%	807,384	6/30/2022
2022 Q1	7/1/2022	4,619	0.0%	807,503	3/31/2022
2021 Q4	2/2/2022	7,327	0.0%	802,568	12/31/2021
2021 Q3	11/2/2021	7,003	0.0%	655,094	9/30/2021
2021 Q2	8/2/2021	5,896	0.0%	379,899	6/30/2021
2021 Q1	5/11/2021	4,082	0.0%	251,831	3/31/2021
2020 Q4	2/8/2021	4,854	0.0%	229,351	12/31/2020
2020 Q3	11/5/2020	3,096	0.0%	208,928	9/30/2020
2020 Q2	8/7/2020	2,784	0.0%	189,228	6/30/2020
2020 Q1	5/6/2020	2,164	0.0%	184,328	3/31/2020
2019 Q4	2/5/2020	4,146	0.0%	176,434	12/31/2019